001023535 001__ 1023535
001023535 005__ 20250204113808.0
001023535 0247_ $$2doi$$a10.1001/jamanetworkopen.2023.52177
001023535 0247_ $$2datacite_doi$$a10.34734/FZJ-2024-01741
001023535 0247_ $$2pmid$$a38236600
001023535 0247_ $$2WOS$$aWOS:001145711600006
001023535 037__ $$aFZJ-2024-01741
001023535 082__ $$a610
001023535 1001_ $$0P:(DE-HGF)0$$aJost, Stefanie T.$$b0$$eCorresponding author
001023535 245__ $$aNeurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years
001023535 260__ $$aChicago, Ill.$$bAmerican Medical Association$$c2024
001023535 3367_ $$2DRIVER$$aarticle
001023535 3367_ $$2DataCite$$aOutput Types/Journal article
001023535 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1708688345_6976
001023535 3367_ $$2BibTeX$$aARTICLE
001023535 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001023535 3367_ $$00$$2EndNote$$aJournal Article
001023535 520__ $$aImportance: Deep brain stimulation of the subthalamic nucleus (STN-DBS) improves quality of life (QOL) in patients with advanced Parkinson disease (PD). However, controlled studies with more than 3 years of follow-up are lacking.Objective: To investigate the long-term effects of STN-DBS on QOL compared with standard-of-care medication (MED).Design, setting, and participants: In this prospective, observational, quasi-experimental, longitudinal nonrandomized controlled trial, 183 patients were screened for eligibility and 167 were enrolled from March 1, 2011, to May 31, 2017, at 3 European university centers. Propensity score matching for demographic and clinical characteristics was applied to 108 patients with PD (62 in the STN-DBS group and 46 in the MED group), resulting in a well-balanced, matched subcohort of 25 patients per group. Data analysis was performed from September 2022 to January 2023.Exposure: Treatment for PD of STN-DBS or MED.Main outcomes and measures: Assessments included Parkinson's Disease Questionnaire 8 (PDQ-8), Unified PD Rating Scale-motor examination, Scales for Outcomes in PD-activities of daily living (ADL) and motor complications, and levodopa-equivalent daily dose. Within-group longitudinal outcome changes, between-group differences, and correlations of change scores were analyzed.Results: The study population in the analysis included 108 patients (mean [SD] age, 63.7 [8.3] years; 66 [61.1%] male). At 5-year follow-up, PDQ-8 and ADL worsened only in the MED group (PDQ-8 change, -10.9; 95% CI, -19.0 to -2.7; P = .01; ADL change: -2.0; 95% CI, -3.1 to -0.8; P = .002), whereas both outcomes remained stable in the STN-DBS group (PDQ-8 change, -4.3; 95% CI, -13.2 to 4.7; P = .34; ADL change, -0.8; 95% CI, -2.5 to 1.0; P = .38). Changes in PDQ-8 and ADL correlated moderately (rs = .40, P = .008). Furthermore, STN-DBS outcomes were favorable for motor complications (median difference in change scores between STN-DBS and MED, -2.0; 95% CI, -4.0 to -1.0; P = .003), mobility (-1.0; 95% CI, -2.0 to 0; P = .03), and levodopa-equivalent daily dose reduction (-821.4; 95% CI, -1111.9 to -530.8; P < .001).Conclusions and relevance: This study provides evidence of differences in QOL outcomes at 5-year follow-up between STN-DBS (stable) and MED (worsened), mainly driven by the favorable effect of STN-DBS on mobility (class IIb evidence). The association between changes in QOL and ADL, but not motor impairment or complications, highlights the relative importance of ADL outcomes for long-term DBS assessments.Trial registration: German ClinicalTrials Registry: DRKS00006735.
001023535 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001023535 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001023535 7001_ $$0P:(DE-HGF)0$$aAloui, Salima$$b1
001023535 7001_ $$0P:(DE-HGF)0$$aEvans, Julian$$b2
001023535 7001_ $$0P:(DE-HGF)0$$aAshkan, Keyoumars$$b3
001023535 7001_ $$0P:(DE-HGF)0$$aSauerbier, Anna$$b4
001023535 7001_ $$0P:(DE-HGF)0$$aRizos, Alexandra$$b5
001023535 7001_ $$0P:(DE-HGF)0$$aPetry-Schmelzer, Jan Niklas$$b6
001023535 7001_ $$0P:(DE-HGF)0$$aGronostay, Alexandra$$b7
001023535 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon R.$$b8
001023535 7001_ $$aVisser-Vandewalle, Veerle$$b9
001023535 7001_ $$aAntonini, Angelo$$b10
001023535 7001_ $$aSilverdale, Monty$$b11
001023535 7001_ $$aTimmermann, Lars$$b12
001023535 7001_ $$aMartinez-Martin, Pablo$$b13
001023535 7001_ $$aChaudhuri, K. Ray$$b14
001023535 7001_ $$aDafsari, Haidar S.$$b15
001023535 7001_ $$aMartinez-Martin, Pablo$$b16
001023535 7001_ $$aRodriguez-Blazquez , Carmen$$b17
001023535 7001_ $$aChaudhuri, Ray$$b18
001023535 7001_ $$aRizos, Alexandra$$b19
001023535 7001_ $$aSauerbier, Anna$$b20
001023535 7001_ $$aParry, Miriam$$b21
001023535 7001_ $$aTrivedi, Dhaval$$b22
001023535 7001_ $$aMartino, Davide$$b23
001023535 7001_ $$aOdin, Per$$b24
001023535 7001_ $$aAntonini, Angelo$$b25
001023535 7001_ $$aStocchi, Fabrizio$$b26
001023535 7001_ $$avan Hilten, Jacobus J$$b27
001023535 7001_ $$avan Laar, Teus$$b28
001023535 7001_ $$aFalup-Pecurariu, Cristian$$b29
001023535 7001_ $$aDietrichs, Espen$$b30
001023535 7001_ $$aLyons, Kelly E.$$b31
001023535 7001_ $$aWeintraub, Dan$$b32
001023535 7001_ $$aKurtis, Monica$$b33
001023535 7001_ $$aSerrano-Dueñas, Marcos$$b34
001023535 7001_ $$aBorges, Vanderci$$b35
001023535 7001_ $$aBehari, Madhuri$$b36
001023535 7001_ $$aBhattacharya, Kalyan$$b37
001023535 7001_ $$aKumar, Hrishikesh$$b38
001023535 7001_ $$aSinghal, Bhim$$b39
001023535 7001_ $$aBhidayasiri, Roongroj$$b40
001023535 7001_ $$aShen-Yang, Lim$$b41
001023535 7001_ $$aGallardo, Marisol$$b42
001023535 7001_ $$aAbe, Kazuo$$b43
001023535 7001_ $$aBostantjopoulou, Sevasti$$b44
001023535 7001_ $$aMartin Rabey, Jose$$b45
001023535 7001_ $$aMicheli, Federico$$b46
001023535 7001_ $$aRodriguez-Violante, Mayela$$b47
001023535 7001_ $$aRiboldazzi, Giulio$$b48
001023535 7001_ $$aCatalan, Maria Jose$$b49
001023535 7001_ $$aEllis, Cathy$$b50
001023535 7001_ $$aBean, Lorna$$b51
001023535 7001_ $$aKessel, Belinda$$b52
001023535 7001_ $$aWorth, Paul$$b53
001023535 7001_ $$aShearing, Gemma$$b54
001023535 7001_ $$aSophia, Rani$$b55
001023535 7001_ $$aSharma, Jagdish$$b56
001023535 7001_ $$aSilverdale, Monty$$b57
001023535 7001_ $$aPal, Suvankar$$b58
001023535 7001_ $$aAshkan, Keyoumars$$b59
001023535 7001_ $$aAdler, Charles$$b60
001023535 7001_ $$aBarone, Paolo$$b61
001023535 7001_ $$aBrooks, David J.$$b62
001023535 7001_ $$aBrown, Richard$$b63
001023535 7001_ $$aCantillon, Marc$$b64
001023535 7001_ $$aCarroll, Camille$$b65
001023535 7001_ $$aCoelho, Miguel$$b66
001023535 7001_ $$aDafsari, Haidar S.$$b67
001023535 7001_ $$aHenriksen, Tove$$b68
001023535 7001_ $$aHu, Michele$$b69
001023535 7001_ $$aJenner, Peter$$b70
001023535 7001_ $$aKramberger, Milica$$b71
001023535 7001_ $$aKumar, Padma$$b72
001023535 7001_ $$aKurtis, Mónica$$b73
001023535 7001_ $$aLewis, Simon$$b74
001023535 7001_ $$aLitvan, Irene$$b75
001023535 7001_ $$aLyons, Kelly$$b76
001023535 7001_ $$aMasellis, Mario$$b77
001023535 7001_ $$aMochizuki, Hideki$$b78
001023535 7001_ $$aMorley, James F.$$b79
001023535 7001_ $$aNirenberg, Melissa$$b80
001023535 7001_ $$aPagonabarraga, Javier$$b81
001023535 7001_ $$aPanicker, Jalesh$$b82
001023535 7001_ $$aPavese, Nicola$$b83
001023535 7001_ $$aPekkonen, Eero$$b84
001023535 7001_ $$aPostuma, Ron$$b85
001023535 7001_ $$aRosales, Raymond$$b86
001023535 7001_ $$aSchapira, Anthony$$b87
001023535 7001_ $$aSimuni, Tanya$$b88
001023535 7001_ $$aSubramanian, Indu$$b89
001023535 7001_ $$aTagliati, Michele$$b90
001023535 7001_ $$aTimmermann, Lars$$b91
001023535 7001_ $$aTinazzi, Michele$$b92
001023535 7001_ $$aToledo, Jon$$b93
001023535 7001_ $$aTsuboi, Yoshio$$b94
001023535 7001_ $$aWalker, Richard$$b95
001023535 773__ $$0PERI:(DE-600)2931249-8$$a10.1001/jamanetworkopen.2023.52177$$gVol. 7, no. 1, p. e2352177 -$$n1$$pe2352177 -$$tJAMA network open$$v7$$x2574-3805$$y2024
001023535 8564_ $$uhttps://juser.fz-juelich.de/record/1023535/files/PDF.pdf$$yOpenAccess
001023535 8564_ $$uhttps://juser.fz-juelich.de/record/1023535/files/PDF.gif?subformat=icon$$xicon$$yOpenAccess
001023535 8564_ $$uhttps://juser.fz-juelich.de/record/1023535/files/PDF.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
001023535 8564_ $$uhttps://juser.fz-juelich.de/record/1023535/files/PDF.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
001023535 8564_ $$uhttps://juser.fz-juelich.de/record/1023535/files/PDF.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
001023535 909CO $$ooai:juser.fz-juelich.de:1023535$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001023535 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b8$$kFZJ
001023535 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001023535 9141_ $$y2024
001023535 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-27
001023535 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001023535 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-10-18T13:36:16Z
001023535 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-10-18T13:36:16Z
001023535 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-27
001023535 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-27
001023535 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001023535 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2021-10-18T13:36:16Z
001023535 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-27
001023535 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJAMA NETW OPEN : 2022$$d2024-12-09
001023535 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-09
001023535 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-09
001023535 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-09
001023535 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-09
001023535 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-09
001023535 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bJAMA NETW OPEN : 2022$$d2024-12-09
001023535 920__ $$lyes
001023535 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
001023535 980__ $$ajournal
001023535 980__ $$aVDB
001023535 980__ $$aUNRESTRICTED
001023535 980__ $$aI:(DE-Juel1)INM-3-20090406
001023535 9801_ $$aFullTexts